1
|
Afzal F, Spieker K, Hurck P, Abt S, Achenbach P, Adlarson P, Ahmed Z, Akondi CS, Annand JRM, Arends HJ, Bashkanov M, Beck R, Biroth M, Borisov N, Braghieri A, Briscoe WJ, Cividini F, Collicott C, Costanza S, Denig A, Dieterle M, Downie EJ, Drexler P, Fegan S, Gardner S, Ghosal D, Glazier DI, Gorodnov I, Gradl W, Gurevich D, Heijkenskjöld L, Hornidge D, Huber GM, Kashevarov VL, Kay SJD, Korolija M, Krusche B, Lazarev A, Livingston K, Lutterer S, MacGregor IJD, Macrae RG, Manley DM, Martel PP, Miskimen R, Mocanu M, Mornacchi E, Mullen C, Neganov A, Neiser A, Oberle M, Ostrick M, Otte PB, Paudyal D, Pedroni P, Powell A, Reicherz G, Rostomyan T, Sfienti C, Sokhoyan V, Steffen O, Strakovsky II, Strub T, Supek I, Thiel A, Thiel M, Thomas A, Usov YA, Wagner S, Walford NK, Watts DP, Werthmüller D, Wettig J, Witthauer L, Wolfes M, Zachariou N. First Measurement Using Elliptically Polarized Photons of the Double-Polarization Observable E for γp→pπ^{0} and γp→nπ^{+}. Phys Rev Lett 2024; 132:121902. [PMID: 38579200 DOI: 10.1103/physrevlett.132.121902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 01/31/2024] [Accepted: 02/02/2024] [Indexed: 04/07/2024]
Abstract
We report the measurement of the helicity asymmetry E for the pπ^{0} and nπ^{+} final states using, for the first time, an elliptically polarized photon beam in combination with a longitudinally polarized target at the Crystal Ball experiment at MAMI. The results agree very well with data that were taken with a circularly polarized photon beam, showing that it is possible to simultaneously measure polarization observables that require linearly (e.g., G) and circularly polarized photons (e.g., E) and a longitudinally polarized target. The new data cover a photon energy range 270-1400 MeV for the pπ^{0} final state (230-842 MeV for the nπ^{+} final state) and the full range of pion polar angles, θ, providing the most precise measurement of the observable E. A moment analysis gives a clear observation of the pη cusp in the pπ^{0} final state.
Collapse
Affiliation(s)
- F Afzal
- Helmholtz-Institut für Strahlen- und Kernphysik, University of Bonn, D-53115 Bonn, Germany
| | - K Spieker
- Helmholtz-Institut für Strahlen- und Kernphysik, University of Bonn, D-53115 Bonn, Germany
| | - P Hurck
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - S Abt
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - P Achenbach
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - P Adlarson
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - Z Ahmed
- University of Regina, Regina, SK S4S0A2, Canada
| | - C S Akondi
- Kent State University, Kent, Ohio 44242, USA
| | - J R M Annand
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - H J Arends
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Bashkanov
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| | - R Beck
- Helmholtz-Institut für Strahlen- und Kernphysik, University of Bonn, D-53115 Bonn, Germany
| | - M Biroth
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N Borisov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Braghieri
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - W J Briscoe
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - F Cividini
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - C Collicott
- Department of Astronomy and Physics, Saint Mary's University, E4L1E6 Halifax, Canada
| | - S Costanza
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
- Dipartimento di Fisica, Università di Pavia, I-27100 Pavia, Italy
| | - A Denig
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Dieterle
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - E J Downie
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - P Drexler
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- II. Physikalisches Institut, University of Giessen, D-35392 Giessen, Germany
| | - S Fegan
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| | - S Gardner
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - D Ghosal
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - D I Glazier
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - I Gorodnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - W Gradl
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Gurevich
- Institute for Nuclear Research, RU-125047 Moscow, Russia
| | - L Heijkenskjöld
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Hornidge
- Mount Allison University, Sackville, New Brunswick E4L1E6, Canada
| | - G M Huber
- University of Regina, Regina, SK S4S0A2, Canada
| | - V L Kashevarov
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S J D Kay
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| | - M Korolija
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - B Krusche
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - A Lazarev
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - K Livingston
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - S Lutterer
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - I J D MacGregor
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - R G Macrae
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - D M Manley
- Kent State University, Kent, Ohio 44242, USA
| | - P P Martel
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- Mount Allison University, Sackville, New Brunswick E4L1E6, Canada
| | - R Miskimen
- University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - M Mocanu
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| | - E Mornacchi
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - C Mullen
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - A Neganov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Neiser
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Oberle
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - M Ostrick
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - P B Otte
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Paudyal
- University of Regina, Regina, SK S4S0A2, Canada
| | - P Pedroni
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - A Powell
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - G Reicherz
- Institut für Experimentalphysik, Ruhr Universität, 44780 Bochum, Germany
| | - T Rostomyan
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - C Sfienti
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - V Sokhoyan
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - O Steffen
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - I I Strakovsky
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - T Strub
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - I Supek
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - A Thiel
- Helmholtz-Institut für Strahlen- und Kernphysik, University of Bonn, D-53115 Bonn, Germany
| | - M Thiel
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - A Thomas
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - Yu A Usov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Wagner
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N K Walford
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - D P Watts
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| | - D Werthmüller
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| | - J Wettig
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - L Witthauer
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - M Wolfes
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N Zachariou
- Department of Physics, University of York, Heslington, York, Y010 5DD, United Kingdom
| |
Collapse
|
2
|
Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon‐Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan‐Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition. EMBO Mol Med 2023; 15:e17719. [PMID: 37966164 PMCID: PMC10701601 DOI: 10.15252/emmm.202317719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2023] [Revised: 10/16/2023] [Accepted: 10/23/2023] [Indexed: 11/16/2023] Open
Abstract
Metastatic uveal melanomas are highly resistant to all existing treatments. To address this critical issue, we performed a kinome-wide CRISPR-Cas9 knockout screen, which revealed the LKB1-SIK2 module in restraining uveal melanoma tumorigenesis. Functionally, LKB1 loss enhances proliferation and survival through SIK2 inhibition and upregulation of the sodium/calcium (Na+ /Ca2+ ) exchanger SLC8A1. This signaling cascade promotes increased levels of intracellular calcium and mitochondrial reactive oxygen species, two hallmarks of cancer. We further demonstrate that combination of an SLC8A1 inhibitor and a mitochondria-targeted antioxidant promotes enhanced cell death efficacy in LKB1- and SIK2-negative uveal melanoma cells compared to control cells. Our study also identified an LKB1-loss gene signature for the survival prognostic of patients with uveal melanoma that may be also predictive of response to the therapy combination. Our data thus identify not only metabolic vulnerabilities but also new prognostic markers, thereby providing a therapeutic strategy for particular subtypes of metastatic uveal melanoma.
Collapse
Affiliation(s)
- Sarah Proteau
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Imène Krossa
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Chrystel Husser
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | | | - Federica Sella
- Department of Dermatology, University Hospital ZurichUniversity of ZurichZurichSwitzerland
| | - Karine Bille
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | | | - Mélanie Dalmasso
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Thibault Barouillet
- Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Yann Cheli
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Céline Pisibon
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Nicole Arrighi
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Sacha Nahon‐Estève
- University Côte d'AzurNiceFrance
- Department of OphthalmologyCentre Hospitalier Universitaire of NiceNiceFrance
| | - Arnaud Martel
- University Côte d'AzurNiceFrance
- Department of OphthalmologyCentre Hospitalier Universitaire of NiceNiceFrance
| | | | - Sandra Lassalle
- University Côte d'AzurNiceFrance
- Laboratory of Clinical and Experimental Pathology, University Hospital of Nice, FHU OncoAge, Cote d'Azur University, Biobank BB‐0033‐00025, IRCAN team 4, OncoAge FHUNiceFrance
| | | | - Patrick Brest
- University Côte d'AzurNiceFrance
- IRCAN team 4, Inserm, CNRS, FHU‐oncoAge, IHU‐RESPIRera NiceNiceFrance
| | - Nathalie M Mazure
- University Côte d'AzurNiceFrance
- Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Frédéric Bost
- University Côte d'AzurNiceFrance
- Inserm, Cancer, Metabolism and environment, team, Equipe labellisée Ligue 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Stéphanie Baillif
- University Côte d'AzurNiceFrance
- Department of OphthalmologyCentre Hospitalier Universitaire of NiceNiceFrance
| | - Solange Landreville
- Département d'ophtalmologie et d'ORL‐CCF, Faculté de médecineUniversité LavalQuebec CityQCCanada
- CUO‐Recherche and Axe médecine régénératriceCentre de recherche du CHU de Québec‐Université LavalQuebec CityQCCanada
- Centre de recherche sur le cancer de l'Université LavalQuebec CityQCCanada
- Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEXQuebec CityQCCanada
| | - Simon Turcotte
- Cancer AxisCentre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de MontréalMontréalQCCanada
- Hepato‐Pancreato‐Biliary Surgery and Liver Transplantation ServiceCentre hospitalier de l'Université de MontréalMontréalQCCanada
| | - Dan Hasson
- Department of Oncological Sciences, Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew YorkNYUSA
- Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) FacilityIcahn School of Medicine at Mount SinaiNew YorkNYUSA
| | - Saul Carcamo
- Department of Oncological Sciences, Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew YorkNYUSA
- Tisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) FacilityIcahn School of Medicine at Mount SinaiNew YorkNYUSA
| | | | - Emily Bernstein
- Department of Oncological Sciences, Tisch Cancer InstituteIcahn School of Medicine at Mount SinaiNew YorkNYUSA
| | - Laurent Yvan‐Charvet
- University Côte d'AzurNiceFrance
- Inserm, Hematometabolism and metainflammation, team 13, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Mitchell P Levesque
- Department of Dermatology, University Hospital ZurichUniversity of ZurichZurichSwitzerland
| | - Robert Ballotti
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Corine Bertolotto
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| | - Thomas Strub
- University Côte d'AzurNiceFrance
- Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020, and Equipe labellisée ARC 2022, Mediterranean Centre for Molecular MedicineNiceFrance
| |
Collapse
|
3
|
Krossa I, Strub T, Aplin AE, Ballotti R, Bertolotto C. Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma? Cancers (Basel) 2022; 14:cancers14194865. [PMID: 36230787 PMCID: PMC9563040 DOI: 10.3390/cancers14194865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 09/27/2022] [Accepted: 09/29/2022] [Indexed: 11/23/2022] Open
Abstract
Simple Summary Epigenetic events, which comprise post-translational modifications of histone tails or DNA methylation, control gene expression by altering chromatin structure without change in the DNA sequence. Histone tails modifications are driven by specific cellular enzymes such as histone methyltransferases or histone acetylases, which play a key role in regulating diverse biological processes. Their alteration may have consequences on growth and tumorigenesis. Abstract Epigenetic regulations, that comprise histone modifications and DNA methylation, are essential to processes as diverse as development and cancer. Among the histone post-translational modifications, lysine methylation represents one of the most important dynamic marks. Here, we focused on methyltransferases of the nuclear binding SET domain 1 (NSD) family, that catalyze the mono- and di-methylation of histone H3 lysine 36. We review the loss of function mutations of NSD1 in humans that are the main cause of SOTOS syndrome, a disease associated with an increased risk of developing cancer. We then report the role of NSD1 in triggering tumor suppressive or promoter functions according to the tissue context and we discuss the role of NSD1 in melanoma. Finally, we examine the ongoing efforts to target NSD1 signaling in cancers.
Collapse
Affiliation(s)
- Imène Krossa
- Université Côte d’Azur, 06100 Nice, France
- Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France
- Correspondence: (I.K.); (C.B.)
| | - Thomas Strub
- Université Côte d’Azur, 06100 Nice, France
- Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France
| | - Andrew E. Aplin
- Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA
| | - Robert Ballotti
- Université Côte d’Azur, 06100 Nice, France
- Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France
| | - Corine Bertolotto
- Université Côte d’Azur, 06100 Nice, France
- Team 1, Biology and Pathologies of melanocytes, Inserm, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2022, Centre Méditerranéen de Médecine Moléculaire, 06200 Nice, France
- Correspondence: (I.K.); (C.B.)
| |
Collapse
|
4
|
Gelmi MC, Houtzagers LE, Strub T, Krossa I, Jager MJ. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance. Int J Mol Sci 2022; 23:6001. [PMID: 35682684 PMCID: PMC9181002 DOI: 10.3390/ijms23116001] [Citation(s) in RCA: 26] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Revised: 05/23/2022] [Accepted: 05/24/2022] [Indexed: 02/04/2023] Open
Abstract
Microphthalmia-associated transcription factor (MITF) is an important regulator of melanogenesis and melanocyte development. Although it has been studied extensively in cutaneous melanoma, the role of MITF in uveal melanoma (UM) has not been explored in much detail. We review the literature about the role of MITF in normal melanocytes, in cutaneous melanoma, and in UM. In normal melanocytes, MITF regulates melanocyte development, melanin synthesis, and melanocyte survival. The expression profile and the behaviour of MITF-expressing cells suggest that MITF promotes local proliferation and inhibits invasion, inflammation, and epithelial-to-mesenchymal (EMT) transition. Loss of MITF expression leads to increased invasion and inflammation and is more prevalent in malignant cells. Cutaneous melanoma cells switch between MITF-high and MITF-low states in different phases of tumour development. In UM, MITF loss is associated with loss of BAP1 protein expression, which is a marker of poor prognosis. These data indicate a dual role for MITF in benign and malignant melanocytic cells.
Collapse
Affiliation(s)
- Maria Chiara Gelmi
- Department of Ophthalmology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands; (M.C.G.); (L.E.H.)
| | - Laurien E. Houtzagers
- Department of Ophthalmology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands; (M.C.G.); (L.E.H.)
| | - Thomas Strub
- Université Côte d’Azur, 06103 Nice, France; (T.S.); (I.K.)
- Inserm, Biology and Pathologies of Melanocytes, Team1, Equipe Labellisée Ligue 2020, Centre Méditerranéen de Médecine Moléculaire, 06204 Nice, France
| | - Imène Krossa
- Université Côte d’Azur, 06103 Nice, France; (T.S.); (I.K.)
- Inserm, Biology and Pathologies of Melanocytes, Team1, Equipe Labellisée Ligue 2020, Centre Méditerranéen de Médecine Moléculaire, 06204 Nice, France
| | - Martine J. Jager
- Department of Ophthalmology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands; (M.C.G.); (L.E.H.)
| |
Collapse
|
5
|
Mornacchi E, Martel PP, Abt S, Achenbach P, Adlarson P, Afzal F, Ahmed Z, Annand JRM, Arends HJ, Bashkanov M, Beck R, Biroth M, Borisov N, Braghieri A, Briscoe WJ, Cividini F, Collicott C, Costanza S, Denig A, Dolzhikov AS, Downie EJ, Drexler P, Fegan S, Gardner S, Ghosal D, Glazier DI, Gorodnov I, Gradl W, Günther M, Gurevich D, Heijkenskjöld L, Hornidge D, Huber GM, Käser A, Kashevarov VL, Kay SJD, Korolija M, Krusche B, Lazarev A, Livingston K, Lutterer S, MacGregor IJD, Manley DM, Miskimen R, Mocanu M, Mullen C, Neganov A, Neiser A, Ostrick M, Paudyal D, Pedroni P, Powell A, Rostomyan T, Sokhoyan V, Spieker K, Steffen O, Strakovsky I, Strub T, Thiel M, Thomas A, Usov YA, Wagner S, Watts DP, Werthmüller D, Wettig J, Wolfes M, Zachariou N. Measurement of Compton Scattering at MAMI for the Extraction of the Electric and Magnetic Polarizabilities of the Proton. Phys Rev Lett 2022; 128:132503. [PMID: 35426697 DOI: 10.1103/physrevlett.128.132503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 01/31/2022] [Accepted: 02/25/2022] [Indexed: 06/14/2023]
Abstract
A precise measurement of the differential cross sections dσ/dΩ and the linearly polarized photon beam asymmetry Σ_{3} for Compton scattering on the proton below pion threshold has been performed with a tagged photon beam and almost 4π detector at the Mainz Microtron. The incident photons were produced by the recently upgraded Glasgow-Mainz photon tagging facility and impinged on a cryogenic liquid hydrogen target, with the scattered photons detected in the Crystal Ball/TAPS setup. Using the highest statistics Compton scattering data ever measured on the proton along with two effective field theories (both covariant baryon and heavy-baryon) and one fixed-t dispersion relation model, constraining the fits with the Baldin sum rule, we have obtained the proton electric and magnetic polarizabilities with unprecedented precision: α_{E1}=10.99±0.16±0.47±0.17±0.34, β_{M1}=3.14±0.21±0.24±0.20±0.35; in units of 10^{-4} fm^{3} where the errors are statistical, systematic, spin polarizability dependent, and model dependent.
Collapse
Affiliation(s)
- E Mornacchi
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - P P Martel
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
- Mount Allison University, Sackville, New Brunswick E4L 1E6, Canada
| | - S Abt
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - P Achenbach
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - P Adlarson
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - F Afzal
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, D-53115 Bonn, Germany
| | - Z Ahmed
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - J R M Annand
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - H J Arends
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - M Bashkanov
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - R Beck
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, D-53115 Bonn, Germany
| | - M Biroth
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - N Borisov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | | | - W J Briscoe
- The George Washington University, Washington, D.C. 20052-0001, USA
| | - F Cividini
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - C Collicott
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - S Costanza
- INFN Sezione di Pavia, I-27100 Pavia, Italy
| | - A Denig
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - A S Dolzhikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - E J Downie
- The George Washington University, Washington, D.C. 20052-0001, USA
| | - P Drexler
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - S Fegan
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - S Gardner
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - D Ghosal
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - D I Glazier
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - I Gorodnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - W Gradl
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - M Günther
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - D Gurevich
- Institute for Nuclear Research, 125047 Moscow, Russia
| | - L Heijkenskjöld
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - D Hornidge
- Mount Allison University, Sackville, New Brunswick E4L 1E6, Canada
| | - G M Huber
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - A Käser
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - V L Kashevarov
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S J D Kay
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - M Korolija
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - B Krusche
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - A Lazarev
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - K Livingston
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S Lutterer
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - I J D MacGregor
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - D M Manley
- Kent State University, Kent, Ohio 44242-0001, USA
| | - R Miskimen
- University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - M Mocanu
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - C Mullen
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A Neganov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Neiser
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - M Ostrick
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - D Paudyal
- University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - P Pedroni
- INFN Sezione di Pavia, I-27100 Pavia, Italy
| | - A Powell
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - T Rostomyan
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - V Sokhoyan
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - K Spieker
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, D-53115 Bonn, Germany
| | - O Steffen
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - I Strakovsky
- The George Washington University, Washington, D.C. 20052-0001, USA
| | - T Strub
- Departement für Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - M Thiel
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - A Thomas
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - Yu A Usov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Wagner
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - D P Watts
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - D Werthmüller
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - J Wettig
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - M Wolfes
- Institut für Kernphysik, Johannes Gutenberg-Universität Mainz, D-55099 Mainz, Germany
| | - N Zachariou
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| |
Collapse
|
6
|
Krossa I, Strub T, Martel A, Nahon-Esteve S, Lassalle S, Hofman P, Baillif S, Ballotti R, Bertolotto C. Recent advances in understanding the role of HES6 in cancers. Theranostics 2022; 12:4374-4385. [PMID: 35673577 PMCID: PMC9169368 DOI: 10.7150/thno.72966] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Accepted: 05/06/2022] [Indexed: 11/05/2022] Open
Abstract
The NOTCH signaling system regulates a variety of cellular processes during embryonic development and homeostasis maintenance in different tissues and contexts. Hence, dysregulation of NOTCH signaling is associated with a plethora of human cancers, and there have been multiple efforts to target key components of this pathway. In this review, we briefly highlight the latest research advances in understanding HES6, a poorly studied component of the NOTCH pathway. We summarize the role of HES6 in cancers with a focus on uveal melanoma. Finally, we discuss the ongoing efforts to target the NOTCH-HES6 axis in cancers.
Collapse
|
7
|
Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease. Cell Death Differ 2021; 28:1990-2000. [PMID: 33462406 PMCID: PMC8185008 DOI: 10.1038/s41418-020-00730-7] [Citation(s) in RCA: 49] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Revised: 12/27/2020] [Accepted: 12/29/2020] [Indexed: 01/30/2023] Open
Abstract
Intratumor heterogeneity has been recognized in numerous cancers as a major source of metastatic dissemination. In uveal melanomas, the existence and identity of specific subpopulations, their biological function and their contribution to metastasis remain unknown. Here, in multiscale analyses using single-cell RNA sequencing of six different primary uveal melanomas, we uncover an intratumoral heterogeneity at the genomic and transcriptomic level. We identify distinct transcriptional cell states and diverse tumor-associated populations in a subset of the samples. We also decipher a gene regulatory network underlying an invasive and poor prognosis state driven in part by the transcription factor HES6. HES6 heterogenous expression has been validated by RNAscope assays within primary human uveal melanomas, which further unveils the existence of these cells conveying a dismal prognosis in tumors diagnosed with a favorable outcome using bulk analyses. Depletion of HES6 impairs proliferation, migration and metastatic dissemination in vitro and in vivo using the chick chorioallantoic membrane assay, demonstrating the essential role of HES6 in uveal melanomas. Thus, single-cell analysis offers an unprecedented view of primary uveal melanoma heterogeneity, identifies bona fide biomarkers for metastatic cells in the primary tumor, and reveals targetable modules driving growth and metastasis formation. Significantly, our findings demonstrate that HES6 is a valid target to stop uveal melanoma progression.
Collapse
Affiliation(s)
- Charlotte Pandiani
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Thomas Strub
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Nicolas Nottet
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Yann Cheli
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Giovanni Gambi
- grid.420255.40000 0004 0638 2716Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
| | - Karine Bille
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Chrystel Husser
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Mélanie Dalmasso
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Guillaume Béranger
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Sandra Lassalle
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Laboratoire de Pathologie clinique et expérimentale, biobanque BB-0033-00025, and IRCAN team 4, FHU OncoAge, Nice, France
| | - Virginie Magnone
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.429194.30000 0004 0638 0649CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France
| | - Florence Pédeutour
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.464719.90000 0004 0639 4696Laboratoire de Génétique des tumeurs solides and IRCAN, Nice, France
| | - Marie Irondelle
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Imagery platform, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Célia Maschi
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Pasteur 2 Teaching Hospital, Department of Ophthalmology, Nice, France
| | - Sacha Nahon-Estève
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Pasteur 2 Teaching Hospital, Department of Ophthalmology, Nice, France
| | - Arnaud Martel
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Pasteur 2 Teaching Hospital, Department of Ophthalmology, Nice, France
| | - Jean-Pierre Caujolle
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Pasteur 2 Teaching Hospital, Department of Ophthalmology, Nice, France
| | - Paul Hofman
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Laboratoire de Pathologie clinique et expérimentale, biobanque BB-0033-00025, and IRCAN team 4, FHU OncoAge, Nice, France
| | - Kévin LeBrigand
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.429194.30000 0004 0638 0649CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France
| | - Irwin Davidson
- grid.420255.40000 0004 0638 2716Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
| | - Stéphanie Baillif
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,Pasteur 2 Teaching Hospital, Department of Ophthalmology, Nice, France
| | - Pascal Barbry
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.429194.30000 0004 0638 0649CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Valbonne, France
| | - Robert Ballotti
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Corine Bertolotto
- grid.460782.f0000 0004 4910 6551Université Côte d’Azur, Nice, France ,grid.462370.40000 0004 0620 5402Inserm, Biology and Pathologies of melanocytes, team1, Equipe labellisée Ligue 2020 and Equipe labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| |
Collapse
|
8
|
Strub T, Martel A, Nahon-Esteve S, Baillif S, Ballotti R, Bertolotto C. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology. Prog Retin Eye Res 2021; 85:100968. [PMID: 33852963 DOI: 10.1016/j.preteyeres.2021.100968] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Revised: 03/22/2021] [Accepted: 03/24/2021] [Indexed: 12/14/2022]
Abstract
Uveal melanoma (UM) is an aggressive and deadly neoplasm. In recent decades, great efforts have been made to obtain a more comprehensive understanding of genetics, genomics and molecular changes in UM, enabling the identification of key cellular processes and signalling pathways. Still, there is no effective treatment for the metastatic disease. Intratumoural heterogeneity (ITH) is thought to be one of the leading determinants of metastasis, therapeutic resistance and recurrence. Crucially, tumours are complex ecosystems, where cancer cells, and diverse cell types from their microenvironment engage in dynamic spatiotemporal crosstalk that allows cancer progression, adaptation and evolution. This highlights the urgent need to gain insight into ITH in UM and its intersection with the microenvironment to overcome treatment failure. Here we provide an overview of the studies and technologies to study ITH in human UMs and tumour micro-environmental composition. We discuss how to incorporate ITH into clinical consideration for the purpose of advocating for new clinical management. We focus on the application of single-cell transcriptomic analysis and propose that understanding the driving forces and functional consequences of the observed tumour heterogeneity holds promise for changing the treatment paradigm of metastatic UMs, surmounting resistance and improving patient prognosis.
Collapse
Affiliation(s)
- Thomas Strub
- University Côte d'Azur, France; Inserm, Biology and Pathologies of Melanocytes, Team1, Equipe Labellisée Ligue 2020 and Equipe Labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Arnaud Martel
- University Côte d'Azur, France; Centre Hospitalier Universitaire de Nice, Department of Ophthalmology, Nice, France
| | - Sacha Nahon-Esteve
- University Côte d'Azur, France; Centre Hospitalier Universitaire de Nice, Department of Ophthalmology, Nice, France
| | - Stéphanie Baillif
- University Côte d'Azur, France; Centre Hospitalier Universitaire de Nice, Department of Ophthalmology, Nice, France
| | - Robert Ballotti
- University Côte d'Azur, France; Inserm, Biology and Pathologies of Melanocytes, Team1, Equipe Labellisée Ligue 2020 and Equipe Labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Corine Bertolotto
- University Côte d'Azur, France; Inserm, Biology and Pathologies of Melanocytes, Team1, Equipe Labellisée Ligue 2020 and Equipe Labellisée ARC 2019, Centre Méditerranéen de Médecine Moléculaire, Nice, France.
| |
Collapse
|
9
|
Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R. Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. Mol Cancer 2021; 20:21. [PMID: 33504341 PMCID: PMC7839296 DOI: 10.1186/s12943-021-01319-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Yann Cheli
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.
| | - Meri K Tulic
- Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France
| | - Najla El Hachem
- Laboratory of Cancer Signaling, University of Liège, Liège, Belgium
| | - Nicolas Nottet
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | - Arnaud Jacquel
- Université Nice Côte d'Azur, INSERM, U1065, Team2 Cell death, differentiation and cancer, 06000, Nice, France
| | - Maeva Gesson
- Université Nice Côte d'Azur, INSERM, U1065, Imaging platform, 06000, Nice, France
| | - Thomas Strub
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | - Karine Bille
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | | | | | - Guillaume E Beranger
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.,Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France
| | - Thierry Passeron
- Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France.,CHU NICE, Département de Dermatologie, 06000, Nice, France
| | - Pierre Close
- Laboratory of Cancer Signaling, University of Liège, Liège, Belgium
| | - Corine Bertolotto
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | - Robert Ballotti
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| |
Collapse
|
10
|
Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R. ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity. Mol Cancer 2021; 20:12. [PMID: 33413419 PMCID: PMC7789764 DOI: 10.1186/s12943-020-01306-2] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 12/29/2020] [Indexed: 02/08/2023] Open
Abstract
Resistances to immunotherapies remains a major hurdle towards a cure for melanoma in numerous patients. An increase in the mesenchymal phenotype and a loss of differentiation have been clearly associated with resistance to targeted therapies. Similar phenotypes have been more recently also linked to resistance to immune checkpoint therapies. We demonstrated here that the loss of MIcrophthalmia associated Transcription Factor (MITF), a pivotal player in melanocyte differentiation, favors the escape of melanoma cells from the immune system. We identified Integrin beta-like protein 1 (ITGBL1), a secreted protein, upregulated in anti-PD1 resistant patients and in MITFlow melanoma cells, as the key immunomodulator. ITGBL1 inhibited immune cell cytotoxicity against melanoma cells by inhibiting NK cells cytotoxicity and counteracting beneficial effects of anti-PD1 treatment, both in vitro and in vivo. Mechanistically, MITF inhibited RUNX2, an activator of ITGBL1 transcription. Interestingly, VitaminD3, an inhibitor of RUNX2, improved melanoma cells to death by immune cells. In conclusion, our data suggest that inhibition of ITGBL1 might improve melanoma response to immunotherapies.
Collapse
Affiliation(s)
- Yann Cheli
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France.
| | - Meri K Tulic
- Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France
| | - Najla El Hachem
- Laboratory of Cancer Signaling, University of Liège, Liège, Belgium
| | - Nicolas Nottet
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | - Arnaud Jacquel
- Université Nice Côte d'Azur, INSERM, U1065, Team2 Cell death, differentiation and cancer, 06000, Nice, France
| | - Maeva Gesson
- Université Nice Côte d'Azur, INSERM, U1065, Imaging platform, 06000, Nice, France
| | - Thomas Strub
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | - Karine Bille
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | | | | | - Guillaume E Beranger
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
- Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France
| | - Thierry Passeron
- Université Nice Côte d'Azur, INSERM, U1065, Team12 Study of the melanocytic differentiation applied to vitiligo and melanoma, 06000, Nice, France
- CHU NICE, Département de Dermatologie, 06000, Nice, France
| | - Pierre Close
- Laboratory of Cancer Signaling, University of Liège, Liège, Belgium
| | - Corine Bertolotto
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| | - Robert Ballotti
- Université Nice Côte d'Azur, INSERM U1065, Team1 Biology and pathologies of melanocytes. Equipe labellisée ARC 2019, 06000, Nice, France
| |
Collapse
|
11
|
Dieterle M, Witthauer L, Fix A, Abt S, Achenbach P, Adlarson P, Afzal F, Aguar Bartolome P, Ahmed Z, Annand JRM, Arends HJ, Bashkanov M, Beck R, Biroth M, Borisov N, Braghieri A, Briscoe WJ, Cividini F, Collicott C, Costanza S, Denig A, Dolzhikov AS, Downie EJ, Drexler P, Gardner S, Ghosal D, Glazier DI, Gorodnov I, Gradl W, Günther M, Gurevich D, Heijkenskjöld L, Hornidge D, Huber GM, Käser A, Kashevarov VL, Kay S, Keshelashvili I, Kondratiev R, Korolija M, Krusche B, Lazarev A, Lisin V, Livingston K, Lutterer S, MacGregor IJD, Manley DM, Martel PP, Metag V, Meyer W, Middleton DG, Miskimen R, Mornacchi E, Mullen C, Mushkarenkov A, Neganov A, Neiser A, Oberle M, Ostrick M, Otte PB, Paudyal D, Pedroni P, Polonski A, Powell A, Prakhov SN, Reicherz G, Ron G, Rostomyan T, Sarty A, Sfienti C, Sokhoyan V, Spieker K, Steffen O, Strakovsky II, Strub T, Supek I, Thiel A, Thiel M, Thomas A, Unverzagt M, Usov YA, Wagner S, Walford NK, Watts DP, Werthmüller D, Wettig J, Wolfes M, Zana LA. Helicity-Dependent Cross Sections for the Photoproduction of π^{0} Pairs from Nucleons. Phys Rev Lett 2020; 125:062001. [PMID: 32845675 DOI: 10.1103/physrevlett.125.062001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2020] [Revised: 05/17/2020] [Accepted: 07/15/2020] [Indexed: 06/11/2023]
Abstract
The double-polarization observable E and helicity-dependent cross sections σ_{1/2}, σ_{3/2} have been measured for the photoproduction of π^{0} pairs off quasifree protons and neutrons at the Mainz MAMI accelerator with the Crystal Ball/TAPS setup. A circularly polarized photon beam was produced by bremsstrahlung from longitudinally polarized electrons and impinged on a longitudinally polarized deuterated butanol target. The reaction products were detected with an almost 4π covering calorimeter. The results reveal for the first time the helicity- and isospin-dependent structure of the γN→Nπ^{0}π^{0} reaction. They are compared to predictions from reaction models in view of nucleon resonance contributions and also to a refit of one model that predicted results for the proton and for the neutron target. The comparison of the prediction and the refit demonstrates the large impact of the new data.
Collapse
Affiliation(s)
- M Dieterle
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - L Witthauer
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - A Fix
- Laboratory of Mathematical Physics, Tomsk Polytechnic University, 634034 Tomsk, Russia
| | - S Abt
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - P Achenbach
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - P Adlarson
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - F Afzal
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - P Aguar Bartolome
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - Z Ahmed
- University of Regina, Regina, Saskatchewan S4S-0A2 Canada
| | - J R M Annand
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - H J Arends
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Bashkanov
- SUPA School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - R Beck
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - M Biroth
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N Borisov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Braghieri
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - W J Briscoe
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - F Cividini
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - C Collicott
- Department of Astronomy and Physics, Saint Mary's University, E4L1E6 Halifax, Canada
| | - S Costanza
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - A Denig
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - A S Dolzhikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - E J Downie
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - P Drexler
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- II. Physikalisches Institut, University of Giessen, D-35392 Giessen, Germany
| | - S Gardner
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - D Ghosal
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - D I Glazier
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
- SUPA School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - I Gorodnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - W Gradl
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Günther
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - D Gurevich
- Institute for Nuclear Research, RU-125047 Moscow, Russia
| | - L Heijkenskjöld
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Hornidge
- Mount Allison University, Sackville, New Brunswick E4L1E6, Canada
| | - G M Huber
- University of Regina, Regina, Saskatchewan S4S-0A2 Canada
| | - A Käser
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - V L Kashevarov
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Kay
- SUPA School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - I Keshelashvili
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - R Kondratiev
- Institute for Nuclear Research, RU-125047 Moscow, Russia
| | - M Korolija
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - B Krusche
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - A Lazarev
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - V Lisin
- Institute for Nuclear Research, RU-125047 Moscow, Russia
| | - K Livingston
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - S Lutterer
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - I J D MacGregor
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - D M Manley
- Kent State University, Kent, Ohio 44242, USA
| | - P P Martel
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- Mount Allison University, Sackville, New Brunswick E4L3B5, Canada
| | - V Metag
- II. Physikalisches Institut, University of Giessen, D-35392 Giessen, Germany
| | - W Meyer
- Institut für Experimentalphysik, Ruhr Universität, 44780 Bochum, Germany
| | - D G Middleton
- Mount Allison University, Sackville, New Brunswick E4L3B5, Canada
| | - R Miskimen
- University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - E Mornacchi
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - C Mullen
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - A Mushkarenkov
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
- University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - A Neganov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Neiser
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Oberle
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - M Ostrick
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - P B Otte
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Paudyal
- University of Regina, Regina, Saskatchewan S4S-0A2 Canada
| | - P Pedroni
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - A Polonski
- Institute for Nuclear Research, RU-125047 Moscow, Russia
| | - A Powell
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - S N Prakhov
- University of California Los Angeles, Los Angeles, California 90095-1547, USA
| | - G Reicherz
- Institut für Experimentalphysik, Ruhr Universität, 44780 Bochum, Germany
| | - G Ron
- Racah Institute of Physics, Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - T Rostomyan
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - A Sarty
- Department of Astronomy and Physics, Saint Mary's University, E4L1E6 Halifax, Canada
| | - C Sfienti
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - V Sokhoyan
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - K Spieker
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - O Steffen
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - I I Strakovsky
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - T Strub
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - I Supek
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - A Thiel
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - M Thiel
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - A Thomas
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Unverzagt
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - Yu A Usov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Wagner
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N K Walford
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
| | - D P Watts
- SUPA School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - D Werthmüller
- Department of Physics, University of Basel, CH-4056 Basel, Switzerland
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, United Kingdom
| | - J Wettig
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Wolfes
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - L A Zana
- SUPA School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| |
Collapse
|
12
|
Louphrasitthiphol P, Siddaway R, Loffreda A, Pogenberg V, Friedrichsen H, Schepsky A, Zeng Z, Lu M, Strub T, Freter R, Lisle R, Suer E, Thomas B, Schuster-Böckler B, Filippakopoulos P, Middleton M, Lu X, Patton EE, Davidson I, Lambert JP, Wilmanns M, Steingrímsson E, Mazza D, Goding CR. Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution. Mol Cell 2020; 79:472-487.e10. [PMID: 32531202 PMCID: PMC7427332 DOI: 10.1016/j.molcel.2020.05.025] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Revised: 04/01/2020] [Accepted: 05/19/2020] [Indexed: 11/06/2022]
Abstract
It is widely assumed that decreasing transcription factor DNA-binding affinity reduces transcription initiation by diminishing occupancy of sequence-specific regulatory elements. However, in vivo transcription factors find their binding sites while confronted with a large excess of low-affinity degenerate motifs. Here, using the melanoma lineage survival oncogene MITF as a model, we show that low-affinity binding sites act as a competitive reservoir in vivo from which transcription factors are released by mitogen-activated protein kinase (MAPK)-stimulated acetylation to promote increased occupancy of their regulatory elements. Consequently, a low-DNA-binding-affinity acetylation-mimetic MITF mutation supports melanocyte development and drives tumorigenesis, whereas a high-affinity non-acetylatable mutant does not. The results reveal a paradoxical acetylation-mediated molecular clutch that tunes transcription factor availability via genome-wide redistribution and couples BRAF to tumorigenesis. Our results further suggest that p300/CREB-binding protein-mediated transcription factor acetylation may represent a common mechanism to control transcription factor availability. Reducing transcription factor DNA-binding affinity increases activity in vivo Acetylation is triggered by MAPK signaling Acetylation leads to genome-wide transcription factor redistribution Acetylation of MITF drives tumorigenesis and melanocyte development
Collapse
Affiliation(s)
- Pakavarin Louphrasitthiphol
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
| | - Robert Siddaway
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Alessia Loffreda
- Experimental Imaging Center, Cancer Imaging Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy; Fondazione CEN, European Center for Nanomedicine, 20133 Milan, Italy
| | - Vivian Pogenberg
- European Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 25a, 22607 Hamburg, Germany & University Hamburg Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
| | - Hans Friedrichsen
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Alexander Schepsky
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Iceland, Sturlugata 8, 101 Reykjavik, Iceland
| | - Zhiqiang Zeng
- MRC Institute of Genetics and Molecular Medicine, MRC Human Genetics Unit and Edinburgh Cancer Research UK Centre, Crewe Road South, Edinburgh EH4 2XR, UK
| | - Min Lu
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Thomas Strub
- Institut de Génetique et Biologie Moléculaire et Cellulaire (IGBMC), Equipe labéllisée Ligue contre le Cancer, 1 rue Laurent Fries, 67404 Illkirch Cedex, France
| | - Rasmus Freter
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Richard Lisle
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Eda Suer
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Benjamin Thomas
- Central Proteomics Facility, Sir William Dunn Pathology School, Oxford University, Oxford OX1 3RE, UK
| | - Benjamin Schuster-Böckler
- Ludwig Institute for Cancer Research, Big Data Institute, University of Oxford, Headington, Oxford OX3 7LF, UK
| | - Panagis Filippakopoulos
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - Mark Middleton
- Oxford NIHR Biomedical Research Centre, Department of Oncology, Churchill Hospital, Oxford OX3 7LE, UK
| | - Xin Lu
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK
| | - E Elizabeth Patton
- MRC Institute of Genetics and Molecular Medicine, MRC Human Genetics Unit and Edinburgh Cancer Research UK Centre, Crewe Road South, Edinburgh EH4 2XR, UK
| | - Irwin Davidson
- Institut de Génetique et Biologie Moléculaire et Cellulaire (IGBMC), Equipe labéllisée Ligue contre le Cancer, 1 rue Laurent Fries, 67404 Illkirch Cedex, France
| | - Jean-Philippe Lambert
- Department of Molecular Medicine and Cancer Research Centre, Université Laval, Quebec, QC, Canada; CHU de Québec Research Center, CHUL, 2705 Boulevard Laurier, Quebec G1V 4G2, QC, Canada
| | - Matthias Wilmanns
- European Molecular Biology Laboratory, Hamburg Unit, Notkestrasse 25a, 22607 Hamburg, Germany & University Hamburg Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
| | - Eiríkur Steingrímsson
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Iceland, Sturlugata 8, 101 Reykjavik, Iceland
| | - Davide Mazza
- Experimental Imaging Center, Cancer Imaging Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy; Fondazione CEN, European Center for Nanomedicine, 20133 Milan, Italy.
| | - Colin R Goding
- Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
| |
Collapse
|
13
|
Bellini L, Strub T, Habel N, Pandiani C, Marchetti S, Martel A, Baillif S, Bailly-Maitre B, Gual P, Ballotti R, Bertolotto C. Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells. Cell Death Discov 2020; 6:22. [PMID: 32337074 PMCID: PMC7165182 DOI: 10.1038/s41420-020-0259-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Revised: 03/26/2020] [Accepted: 03/28/2020] [Indexed: 12/15/2022] Open
Abstract
To address unmet clinical need for uveal melanomas, we assessed the effects of BH3-mimetic molecules, the ABT family, known to exert pro-apoptotic activities in cancer cells. Our results uncovered that ABT-263 (Navitoclax), a potent and orally bioavailable BCL-2 family inhibitor, induced antiproliferative effects in metastatic human uveal melanoma cells through cell cycle arrest at the G0/G1 phase, loss of mitochondrial membrane potential, and subsequently apoptotic cell death monitored by caspase activation and poly-ADP ribose polymerase cleavage. ABT-263-mediated reduction in tumor growth was also observed in vivo. We observed in some cells that ABT-263 treatment mounted a pro-survival response through activation of the ER stress signaling pathway. Blocking the PERK signaling pathway increased the pro-apoptotic ABT-263 effect. We thus uncovered a resistance mechanism in uveal melanoma cells mediated by activation of endoplasmic reticulum stress pathway. Therefore, our study identifies ABT-263 as a valid therapeutic option for patients suffering from uveal melanoma.
Collapse
Affiliation(s)
- Lara Bellini
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
| | - Thomas Strub
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
| | - Nadia Habel
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
| | - Charlotte Pandiani
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
| | - Sandrine Marchetti
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Metabolism, cancer and immune response, team 3, Nice, France
| | - Arnaud Martel
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
- CHU NICE, Département d’Ophtalmologie, Nice, France
| | - Stéphanie Baillif
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
- CHU NICE, Département d’Ophtalmologie, Nice, France
| | - Béatrice Bailly-Maitre
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Chronic liver diseases associated with obesity and alcohol, team8, Nice, France
| | - Philippe Gual
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Chronic liver diseases associated with obesity and alcohol, team8, Nice, France
| | - Robert Ballotti
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
| | - Corine Bertolotto
- Université Nice Côte d’Azur, Inserm, C3M Nice, France
- INSERM, U1065, Biology and pathologies of melanocytes, team 1. Equipe labellisée Ligue 2020, Nice, France
| |
Collapse
|
14
|
Bashkanov M, Watts DP, Kay SJD, Abt S, Achenbach P, Adlarson P, Afzal F, Ahmed Z, Akondi CS, Annand JRM, Arends HJ, Beck R, Biroth M, Borisov N, Braghieri A, Briscoe WJ, Cividini F, Collicott C, Costanza S, Denig A, Downie EJ, Drexler P, Fegan S, Fix A, Gardner S, Ghosal D, Glazier DI, Gorodnov I, Gradl W, Günther M, Gurevich D, Heijkenskjöld L, Hornidge D, Huber GM, Käser A, Kashevarov VL, Korolija M, Krusche B, Lazarev A, Livingston K, Lutterer S, MacGregor IJD, Manley DM, Martel PP, Miskimen R, Mornacchi E, Mullen C, Neganov A, Neiser A, Ostrick M, Otte PB, Paudyal D, Pedroni P, Powell A, Prakhov SN, Ron G, Sarty A, Sfienti C, Sokhoyan V, Spieker K, Steffen O, Strakovsky II, Strub T, Supek I, Thiel A, Thiel M, Thomas A, Usov YA, Wagner S, Walford NK, Werthmüller D, Wettig J, Wolfes M, Zachariou N, Zana LA. Signatures of the d^{*}(2380) Hexaquark in d(γ,pn[over →]). Phys Rev Lett 2020; 124:132001. [PMID: 32302204 DOI: 10.1103/physrevlett.124.132001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2019] [Revised: 01/30/2020] [Accepted: 03/02/2020] [Indexed: 06/11/2023]
Abstract
We report a measurement of the spin polarization of the recoiling neutron in deuterium photodisintegration, utilizing a new large acceptance polarimeter within the Crystal Ball at MAMI. The measured photon energy range of 300-700 MeV provides the first measurement of recoil neutron polarization at photon energies where the quark substructure of the deuteron plays a role, thereby providing important new constraints on photodisintegration mechanisms. A very high neutron polarization in a narrow structure centered around E_{γ}∼570 MeV is observed, which is inconsistent with current theoretical predictions employing nucleon resonance degrees of freedom. A Legendre polynomial decomposition suggests this behavior could be related to the excitation of the d^{*}(2380) hexaquark.
Collapse
Affiliation(s)
- M Bashkanov
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - D P Watts
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - S J D Kay
- University of Regina, Regina, SK S4S0A2 Canada
| | - S Abt
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - P Achenbach
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - P Adlarson
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - F Afzal
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - Z Ahmed
- University of Regina, Regina, SK S4S0A2 Canada
| | - C S Akondi
- Kent State University, Kent, Ohio 44242, USA
| | - J R M Annand
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - H J Arends
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - R Beck
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - M Biroth
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N Borisov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Braghieri
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - W J Briscoe
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - F Cividini
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - C Collicott
- Department of Astronomy and Physics, Saint Mary's University, E4L1E6 Halifax, Canada
| | - S Costanza
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
- Dipartimento di Fisica, Università di Pavia, I-27100 Pavia, Italy
| | - A Denig
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - E J Downie
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - P Drexler
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- II. Physikalisches Institut, University of Giessen, D-35392 Giessen, Germany
| | - S Fegan
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - A Fix
- Tomsk Polytechnic University, 634034 Tomsk, Russia
| | - S Gardner
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - D Ghosal
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - D I Glazier
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - I Gorodnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - W Gradl
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Günther
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - D Gurevich
- Institute for Nuclear Research, RU-125047 Moscow, Russia
| | - L Heijkenskjöld
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Hornidge
- Mount Allison University, Sackville, New Brunswick E4L1E6, Canada
| | - G M Huber
- University of Regina, Regina, SK S4S0A2 Canada
| | - A Käser
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - V L Kashevarov
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - M Korolija
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - B Krusche
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - A Lazarev
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - K Livingston
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S Lutterer
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - I J D MacGregor
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - D M Manley
- Kent State University, Kent, Ohio 44242, USA
| | - P P Martel
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
- Mount Allison University, Sackville, New Brunswick E4L1E6, Canada
| | - R Miskimen
- University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - E Mornacchi
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - C Mullen
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - A Neganov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Neiser
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Ostrick
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - P B Otte
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - D Paudyal
- University of Regina, Regina, SK S4S0A2 Canada
| | - P Pedroni
- INFN Sezione di Pavia, I-27100 Pavia, Pavia, Italy
| | - A Powell
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - S N Prakhov
- University of California Los Angeles, Los Angeles, California 90095-1547, USA
| | - G Ron
- Racah Institute of Physics, Hebrew University of Jerusalem, Jerusalem 91904, Israel
| | - A Sarty
- Department of Astronomy and Physics, Saint Mary's University, E4L1E6 Halifax, Canada
| | - C Sfienti
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - V Sokhoyan
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - K Spieker
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - O Steffen
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - I I Strakovsky
- Center for Nuclear Studies, The George Washington University, Washington, DC 20052, USA
| | - T Strub
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - I Supek
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - A Thiel
- Helmholtz-Institut für Strahlen- und Kernphysik, University Bonn, D-53115 Bonn, Germany
| | - M Thiel
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - A Thomas
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - Yu A Usov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - S Wagner
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N K Walford
- Department of Physics, University of Basel, Ch-4056 Basel, Switzerland
| | - D Werthmüller
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - J Wettig
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - M Wolfes
- Institut für Kernphysik, University of Mainz, D-55099 Mainz, Germany
| | - N Zachariou
- Department of Physics, University of York, Heslington, York Y010 5DD, United Kingdom
| | - L A Zana
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| |
Collapse
|
15
|
Strub T, Ballotti R, Bertolotto C. The "ART" of Epigenetics in Melanoma: From histone "Alterations, to Resistance and Therapies". Theranostics 2020; 10:1777-1797. [PMID: 32042336 PMCID: PMC6993228 DOI: 10.7150/thno.36218] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2019] [Accepted: 11/14/2019] [Indexed: 02/07/2023] Open
Abstract
Malignant melanoma is the most deadly form of skin cancer. It originates from melanocytic cells and can also arise at other body sites. Early diagnosis and appropriate medical care offer excellent prognosis with up to 5-year survival rate in more than 95% of all patients. However, long-term survival rate for metastatic melanoma patients remains at only 5%. Indeed, malignant melanoma is known for its notorious resistance to most current therapies and is characterized by both genetic and epigenetic alterations. In cutaneous melanoma (CM), genetic alterations have been implicated in drug resistance, yet the main cause of this resistance seems to be non-genetic in nature with a change in transcription programs within cell subpopulations. This change can adapt and escape targeted therapy and immunotherapy cytotoxic effects favoring relapse. Because they are reversible in nature, epigenetic changes are a growing focus in cancer research aiming to prevent or revert the drug resistance with current therapies. As such, the field of epigenetic therapeutics is among the most active area of preclinical and clinical research with effects of many classes of epigenetic drugs being investigated. Here, we review the multiplicity of epigenetic alterations, mainly histone alterations and chromatin remodeling in both cutaneous and uveal melanomas, opening opportunities for further research in the field and providing clues to specifically control these modifications. We also discuss how epigenetic dysregulations may be exploited to achieve clinical benefits for the patients, the limitations of these therapies, and recent data exploring this potential through combinatorial epigenetic and traditional therapeutic approaches.
Collapse
Affiliation(s)
- Thomas Strub
- Université Nice Côte d'Azur, Inserm, C3M, France
- Biology and pathologies of melanocytes, Equipe labellisée ARC 2019, C3M, team 1, France
| | - Robert Ballotti
- Université Nice Côte d'Azur, Inserm, C3M, France
- Biology and pathologies of melanocytes, Equipe labellisée ARC 2019, C3M, team 1, France
| | - Corine Bertolotto
- Université Nice Côte d'Azur, Inserm, C3M, France
- Biology and pathologies of melanocytes, Equipe labellisée ARC 2019, C3M, team 1, France
| |
Collapse
|
16
|
Strub T, Ghiraldini FG, Carcamo S, Li M, Wroblewska A, Singh R, Goldberg MS, Hasson D, Wang Z, Gallagher SJ, Hersey P, Ma'ayan A, Long GV, Scolyer RA, Brown B, Zheng B, Bernstein E. SIRT6 haploinsufficiency induces BRAF V600E melanoma cell resistance to MAPK inhibitors via IGF signalling. Nat Commun 2018; 9:3440. [PMID: 30143629 PMCID: PMC6109055 DOI: 10.1038/s41467-018-05966-z] [Citation(s) in RCA: 62] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Accepted: 07/24/2018] [Indexed: 12/23/2022] Open
Abstract
While multiple mechanisms of BRAFV600-mutant melanoma resistance to targeted MAPK signaling inhibitors (MAPKi) have been reported, the epigenetic regulation of this process remains undetermined. Here, using a CRISPR–Cas9 screen targeting chromatin regulators, we discover that haploinsufficiency of the histone deacetylase SIRT6 allows melanoma cell persistence in the presence of MAPKi. Haploinsufficiency, but not complete loss of SIRT6 promotes IGFBP2 expression via increased chromatin accessibility, H3K56 acetylation at the IGFBP2 locus, and consequent activation of the IGF-1 receptor (IGF-1R) and downstream AKT signaling. Combining a clinically applicable IGF-1Ri with BRAFi overcomes resistance of SIRT6 haploinsufficient melanoma cells in vitro and in vivo. Using matched melanoma samples derived from patients receiving dabrafenib + trametinib, we identify IGFBP2 as a potential biomarker for MAPKi resistance. Our study has not only identified an epigenetic mechanism of drug resistance, but also provides insights into a combinatorial therapy that may overcome resistance to standard-of-care therapy for BRAFV600-mutant melanoma patients. The epigenetic mechanisms of melanoma drug resistance are poorly understood. Here, the authors develop a CRISPR-Cas9 screen targeting epigenetic regulators and discover that SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.
Collapse
Affiliation(s)
- Thomas Strub
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Flavia G Ghiraldini
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Saul Carcamo
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Man Li
- Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA
| | - Aleksandra Wroblewska
- Department of Genetics and Genomic Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Rajendra Singh
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Pathology, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Matthew S Goldberg
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Pathology, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Dan Hasson
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Zichen Wang
- Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Stuart J Gallagher
- Centenary Institute, Camperdown NSW 2050, The University of Sydney, Sydney, Australia.,Melanoma Institute Australia, Wollstonecraft NSW 2065, The University of Sydney, Sydney, Australia
| | - Peter Hersey
- Centenary Institute, Camperdown NSW 2050, The University of Sydney, Sydney, Australia.,Melanoma Institute Australia, Wollstonecraft NSW 2065, The University of Sydney, Sydney, Australia
| | - Avi Ma'ayan
- Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Georgina V Long
- Melanoma Institute Australia, Wollstonecraft NSW 2065, The University of Sydney, Sydney, Australia.,Sydney Medical School, University of Sydney, Sydney, NSW, 2050, Australia.,Royal North Shore Hospital, Sydney, NSW, 2065, Australia
| | - Richard A Scolyer
- Melanoma Institute Australia, Wollstonecraft NSW 2065, The University of Sydney, Sydney, Australia.,Sydney Medical School, University of Sydney, Sydney, NSW, 2050, Australia.,Royal Prince Alfred Hospital, Sydney, NSW, 2050, Australia
| | - Brian Brown
- Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Department of Genetics and Genomic Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.,Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA
| | - Bin Zheng
- Centenary Institute, Camperdown NSW 2050, The University of Sydney, Sydney, Australia
| | - Emily Bernstein
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. .,Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. .,Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.
| |
Collapse
|
17
|
Bonet C, Luciani F, Ottavi JF, Leclerc J, Jouenne FM, Boncompagni M, Bille K, Hofman V, Bossis G, Marco de Donatis G, Strub T, Cheli Y, Ohanna M, Luciano F, Marchetti S, Rocchi S, Birling MC, Avril MF, Poulalhon N, Luc T, Hofman P, Lacour JP, Davidson I, Bressac-de Paillerets B, Ballotti R, Marine JC, Bertolotto C. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression. J Natl Cancer Inst 2017; 109:3071266. [PMID: 28376192 DOI: 10.1093/jnci/djw340] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2016] [Accepted: 12/22/2016] [Indexed: 01/20/2023] Open
Abstract
Background MITF encodes an oncogenic lineage-specific transcription factor in which a germline mutation ( MITFE318K ) was identified in human patients predisposed to both nevus formation and, among other tumor types, melanoma. The molecular mechanisms underlying the oncogenic activity of MITF E318K remained uncharacterized. Methods Here, we compared the SUMOylation status of endogenous MITF by proximity ligation assay in melanocytes isolated from wild-type (n = 3) or E318K (n = 4) MITF donors. We also used a newly generated Mitf E318K knock-in (KI) mouse model to assess the role of Mitf E318K (n = 7 to 13 mice per group) in tumor development in vivo and performed transcriptomic analysis of the tumors to identify the molecular mechanisms. Finally, using immortalized or normal melanocytes (wild-type or E318K MITF, n = 2 per group), we assessed the role of MITF E318K on the induction of senescence mediated by BRAF V600E . All statistical tests were two-sided. Results We demonstrated a decrease in endogenous MITF SUMOylation in melanocytes from MITF E318K patients (mean of cells with hypoSUMOylated MITF, MITF E318K vs MITF WT , 94% vs 44%, difference = 50%, 95% CI = 21.8% to 67.2%, P = .004). The Mitf E318K mice were slightly hypopigmented (mean melanin content Mitf WT vs Mitf E318K/+ , 0.54 arbitrary units [AU] vs 0.36 AU, difference = -0.18, 95% CI = -0.36 to -0.007, P = .04). We provided genetic evidence that Mitf E318K enhances BRaf V600E -induced nevus formation in vivo (mean nevus number for Mitf E318K , BRaf V600E vs Mitf WT , BRaf V600E , 68 vs 44, difference = 24, 95% CI = 9.1 to 38.9, P = .006). Importantly, although Mitf E318K was not sufficient to cooperate with BRaf V600E alone in promoting metastatic melanoma, it accelerated tumor formation on a BRaf V600E , Pten-deficient background (median survival, Mitf E318K/+ = 42 days, 95% CI = 31 to 46 vs Mitf WT = 51 days, 95% CI = 50 to 55, P < .001). Transcriptome analysis suggested a decrease in senescence in tumors from Mitf E318K mice. We confirmed this hypothesis by in vitro experiments, demonstrating that Mitf E318K impaired the ability of human melanocytes to undergo BRAF V600E -induced senescence. Conclusions We characterized the functions of melanoma-associated MITF E318K mutations. Our results demonstrate that MITF E318K reduces the program of senescence to potentially favor melanoma progression in vivo.
Collapse
Affiliation(s)
- Caroline Bonet
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Flavie Luciani
- Center for Human Genetics, KU Leuven, Leuven, Belgium.,Center for the Biology of Disease, VIB, Leuven, Belgium
| | - Jean-François Ottavi
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Justine Leclerc
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | | | - Marina Boncompagni
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Karine Bille
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Véronique Hofman
- University of Nice Sophia-Antipolis, UFR Médecine, Nice, France.,Inserm, ERI21/EA 4319, Nice, France
| | | | | | - Thomas Strub
- Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, Université de Strasbourg, Illkirch, France
| | - Yann Cheli
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Mickaël Ohanna
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | | | | | - Stéphane Rocchi
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Marie-Christine Birling
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,Institut Clinique de la Souris-Mouse Clinical Institute, Illkirch, France
| | - Marie-Françoise Avril
- AP-HP, Hôpital Cochin -Tarnier, Service de Dermatologie et Faculté Paris Descartes, Paris, France
| | - Nicolas Poulalhon
- Centre Hospitalier Universitaire de Lyon, Department of Dermatology, Lyon, France
| | - Thomas Luc
- Centre Hospitalier Universitaire de Lyon, Department of Dermatology, Lyon, France
| | - Paul Hofman
- University of Nice Sophia-Antipolis, UFR Médecine, Nice, France.,Inserm, ERI21/EA 4319, Nice, France
| | | | - Irwin Davidson
- Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, Université de Strasbourg, Illkirch, France
| | - Brigitte Bressac-de Paillerets
- Service de Génétique, Institut de Cancérologie Gustave Roussy, Villejuif, France.,INSERM U1186, Immunologie intégrative des tumeurs et génétique oncologique, Paris, France
| | - Robert Ballotti
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| | - Jean-Christophe Marine
- Center for Human Genetics, KU Leuven, Leuven, Belgium.,Center for the Biology of Disease, VIB, Leuven, Belgium
| | - Corine Bertolotto
- INSERM, U1065 (équipe 1), Equipe labélisée ARC 2016, C3M, Nice, France.,University of Nice Sophia-Antipolis, UFR Médecine, Nice, France
| |
Collapse
|
18
|
Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K, Dessen P, d'Hayer B, Mohamdi H, Remenieras A, Maubec E, de la Fouchardière A, Molinié V, Vabres P, Dalle S, Poulalhon N, Martin-Denavit T, Thomas L, Andry-Benzaquen P, Dupin N, Boitier F, Rossi A, Perrot JL, Labeille B, Robert C, Escudier B, Caron O, Brugières L, Saule S, Gardie B, Gad S, Richard S, Couturier J, Teh BT, Ghiorzo P, Pastorino L, Puig S, Badenas C, Olsson H, Ingvar C, Rouleau E, Lidereau R, Bahadoran P, Vielh P, Corda E, Blanché H, Zelenika D, Galan P, Chaudru V, Lenoir GM, Lathrop M, Davidson I, Avril MF, Demenais F, Ballotti R, Bressac-de Paillerets B. Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2015; 531:126. [PMID: 26633630 DOI: 10.1038/nature16158] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
19
|
Koludrovic D, Laurette P, Strub T, Keime C, Le Coz M, Coassolo S, Mengus G, Larue L, Davidson I. Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells. PLoS Genet 2015; 11:e1005555. [PMID: 26440048 PMCID: PMC4595011 DOI: 10.1371/journal.pgen.1005555] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Accepted: 09/07/2015] [Indexed: 12/23/2022] Open
Abstract
MIcrophthalmia-associated Transcription Factor (MITF) regulates melanocyte and melanoma physiology. We show that MITF associates the NURF chromatin-remodelling factor in melanoma cells. ShRNA-mediated silencing of the NURF subunit BPTF revealed its essential role in several melanoma cell lines and in untransformed melanocytes in vitro. Comparative RNA-seq shows that MITF and BPTF co-regulate overlapping gene expression programs in cell lines in vitro. Somatic and specific inactivation of Bptf in developing murine melanoblasts in vivo shows that Bptf regulates their proliferation, migration and morphology. Once born, Bptf-mutant mice display premature greying where the second post-natal coat is white. This second coat is normally pigmented by differentiated melanocytes derived from the adult melanocyte stem cell (MSC) population that is stimulated to proliferate and differentiate at anagen. An MSC population is established and maintained throughout the life of the Bptf-mutant mice, but these MSCs are abnormal and at anagen, give rise to reduced numbers of transient amplifying cells (TACs) that do not express melanocyte markers and fail to differentiate into mature melanin producing melanocytes. MSCs display a transcriptionally repressed chromatin state and Bptf is essential for reactivation of the melanocyte gene expression program at anagen, the subsequent normal proliferation of TACs and their differentiation into mature melanocytes. The melanocytes pigmenting the coat of adult mice derive from the melanocyte stem cell population residing in the permanent bulge area of the hair follicle. At each angen phase, melanocyte stem cells are stimulated to generate proliferative transient amplifying cells that migrate to the bulb of the follicle where they differentiate into mature melanin producing melanocytes, a processes involving MIcrophthalmia-associated Transcription Factor (MITF) the master regulator of the melanocyte lineage. We show that MITF associates with the NURF chromatin-remodelling factor in melanoma cells. NURF acts downstream of MITF in melanocytes and melanoma cells co-regulating gene expression in vitro. In vivo, mice lacking the NURF subunit Bptf in the melanocyte lineage show premature greying as they are unable to generate mature melanocytes from the adult stem cell population. We find that the melanocyte stem cells from these animals are abnormal and that once they are stimulated at anagen, Bptf is required to ensure the expression of melanocyte markers and their differentiation into mature adult melanocytes. Chromatin remodelling by NURF therefore appears to be essential for the transition of the transcriptionally quiescent stem cell to the differentiated state.
Collapse
Affiliation(s)
- Dana Koludrovic
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France
- Beaston Institute for Cancer Research, Glasgow, United Kingdom
| | - Patrick Laurette
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France
| | - Thomas Strub
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America
| | - Céline Keime
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France
| | - Madeleine Le Coz
- Institut Curie CNRS UMR3347, INSERM U1021, Bat 110, Orsay, France
| | - Sebastien Coassolo
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France
| | - Gabrielle Mengus
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France
| | - Lionel Larue
- Institut Curie CNRS UMR3347, INSERM U1021, Bat 110, Orsay, France
- Equipes labélisées Ligue Contre le Cancer, Orsay and Strasbourg, France
| | - Irwin Davidson
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France
- Equipes labélisées Ligue Contre le Cancer, Orsay and Strasbourg, France
- * E-mail:
| |
Collapse
|
20
|
Vardabasso C, Gaspar-Maia A, Punzeler S, Valle-Garcia D, Hasson D, Straub T, Keilhauer EC, Strub T, Panda T, Segura MF, Chung CY, Verma AK, Mann M, Hernando E, Hake SB, Bernstein E. Abstract A12: Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma. Cancer Res 2015. [DOI: 10.1158/1538-7445.mel2014-a12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Malignant melanoma is the most lethal form of skin cancer with rising incidence. Once metastasis occurs, patients have a dismal prognosis, largely due to limited systemic treatment with chemotherapy and resistance to targeted therapies. Thus, effective therapies with long-term responses are currently lacking. Although much effort has focused on characterizing and targeting the genetic alterations in melanoma, the identification of epigenetic players remains poorly understood. Chromatin dynamics have recently been shown to exert a critical function in a number of cancers, including melanoma, and emerging evidence points towards a role of histone variants as key regulatory molecules in cancer.
H2A.Z is a highly conserved H2A variant, harboring two different isoforms in vertebrates, H2A.Z.1 and H2A.Z.2. High levels of H2A.Z promote cell proliferation in breast, prostate and bladder cancers, however studies so far have focused primarily on H2A.Z.1 or did not clearly distinguish between the two isoforms.
Here, we report a role for the unappreciated isoform H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma. To our knowledge, this is the first evidence to implicate a distinct role for this H2A.Z isoform in any tumor type. While both H2A.Z.1 and H2A.Z.2 are highly expressed in metastatic melanoma and correlate with decreased patient survival, only H2A.Z.2 deficiency results in impaired cellular proliferation, which occurs through a G1 to S arrest. Integrated gene expression and ChIP-seq analyses revealed that H2A.Z.2 positively regulates E2F target genes, which are highly expressed and acquire a distinct H2A.Z occupancy signature over the promoter and gene body in metastatic cells. We further identified the BET (bromodomain and extraterminal domain) family member BRD2 as an H2A.Z-interacting protein in melanoma cells, and our data suggest that H2A.Z.2 exerts its oncogenic function by maintaining the global levels of BRD2 and histone H4 acetylation. Furthermore, H2A.Z.2 depletion sensitizes melanoma cells to targeted therapies and chemotherapy. Collectively, our findings implicate H2A.Z.2 as a driver of melanoma pathogenesis. Owing to the fact that histone modification is a reversible process, H2A.Z.2 and BRD2 hold translational potential for novel therapeutic strategies.
Citation Format: Chiara Vardabasso, Alexandre Gaspar-Maia, Sebastian Punzeler, David Valle-Garcia, Dan Hasson, Tobias Straub, Eva C. Keilhauer, Thomas Strub, Taniya Panda, Miguel F. Segura, Chi-Yeh Chung, Amit K. Verma, Matthias Mann, Eva Hernando, Sandra B. Hake, Emily Bernstein. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Melanoma: From Biology to Therapy; Sep 20-23, 2014; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(14 Suppl):Abstract nr A12.
Collapse
Affiliation(s)
| | | | - Sebastian Punzeler
- 2Adolf-Butenandt Institute, Ludwig-Maximilians University, Munich, Germany,
| | | | - Dan Hasson
- 1Icahn School of Medicine at Mount Sinai, New York, NY,
| | - Tobias Straub
- 2Adolf-Butenandt Institute, Ludwig-Maximilians University, Munich, Germany,
| | | | - Thomas Strub
- 1Icahn School of Medicine at Mount Sinai, New York, NY,
| | - Taniya Panda
- 1Icahn School of Medicine at Mount Sinai, New York, NY,
| | | | - Chi-Yeh Chung
- 1Icahn School of Medicine at Mount Sinai, New York, NY,
| | | | - Matthias Mann
- 3Max-Planck Institute for Biochemistry, Martinsried, Germany,
| | - Eva Hernando
- 4New York University Langone Medical Center, New York, NY,
| | - Sandra B. Hake
- 2Adolf-Butenandt Institute, Ludwig-Maximilians University, Munich, Germany,
| | | |
Collapse
|
21
|
Vardabasso C, Gaspar-Maia A, Hasson D, Pünzeler S, Valle-Garcia D, Straub T, Keilhauer EC, Strub T, Dong J, Panda T, Chung CY, Yao JL, Singh R, Segura MF, Fontanals-Cirera B, Verma A, Mann M, Hernando E, Hake SB, Bernstein E. Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. Mol Cell 2015; 59:75-88. [PMID: 26051178 DOI: 10.1016/j.molcel.2015.05.009] [Citation(s) in RCA: 138] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2014] [Revised: 03/24/2015] [Accepted: 04/30/2015] [Indexed: 01/19/2023]
Abstract
Histone variants are emerging as key regulatory molecules in cancer. We report a unique role for the H2A.Z isoform H2A.Z.2 as a driver of malignant melanoma. H2A.Z.2 is highly expressed in metastatic melanoma, correlates with decreased patient survival, and is required for cellular proliferation. Our integrated genomic analyses reveal that H2A.Z.2 controls the transcriptional output of E2F target genes in melanoma cells. These genes are highly expressed and display a distinct signature of H2A.Z occupancy. We identify BRD2 as an H2A.Z-interacting protein, levels of which are also elevated in melanoma. We further demonstrate that H2A.Z.2-regulated genes are bound by BRD2 and E2F1 in an H2A.Z.2-dependent manner. Importantly, H2A.Z.2 deficiency sensitizes melanoma cells to chemotherapy and targeted therapies. Collectively, our findings implicate H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma, holding translational potential for novel therapeutic strategies.
Collapse
Affiliation(s)
- Chiara Vardabasso
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Alexandre Gaspar-Maia
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Dan Hasson
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Sebastian Pünzeler
- Center for Integrated Protein Science Munich and Department of Molecular Biology, Adolf-Butenandt Institute, Ludwig-Maximilians University, 80336 Munich, Germany
| | - David Valle-Garcia
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Molecular Genetics Department, Institute for Cellular Physiology, National Autonomous University of Mexico, 04510 Mexico City, Mexico
| | - Tobias Straub
- Center for Integrated Protein Science Munich and Department of Molecular Biology, Adolf-Butenandt Institute, Ludwig-Maximilians University, 80336 Munich, Germany
| | - Eva C Keilhauer
- Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
| | - Thomas Strub
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Joanna Dong
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Taniya Panda
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Chi-Yeh Chung
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Jonathan L Yao
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Rajendra Singh
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Miguel F Segura
- Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY 10016, USA
| | - Barbara Fontanals-Cirera
- Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY 10016, USA
| | - Amit Verma
- Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
| | - Matthias Mann
- Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
| | - Eva Hernando
- Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY 10016, USA
| | - Sandra B Hake
- Center for Integrated Protein Science Munich and Department of Molecular Biology, Adolf-Butenandt Institute, Ludwig-Maximilians University, 80336 Munich, Germany.
| | - Emily Bernstein
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
| |
Collapse
|
22
|
Laurette P, Strub T, Koludrovic D, Keime C, Le Gras S, Seberg H, Van Otterloo E, Imrichova H, Siddaway R, Aerts S, Cornell RA, Mengus G, Davidson I. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells. eLife 2015; 4. [PMID: 25803486 PMCID: PMC4407272 DOI: 10.7554/elife.06857] [Citation(s) in RCA: 117] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Accepted: 03/24/2015] [Indexed: 12/17/2022] Open
Abstract
Microphthalmia-associated transcription factor (MITF) is the master regulator of the melanocyte lineage. To understand how MITF regulates transcription, we used tandem affinity purification and mass spectrometry to define a comprehensive MITF interactome identifying novel cofactors involved in transcription, DNA replication and repair, and chromatin organisation. We show that MITF interacts with a PBAF chromatin remodelling complex comprising BRG1 and CHD7. BRG1 is essential for melanoma cell proliferation in vitro and for normal melanocyte development in vivo. MITF and SOX10 actively recruit BRG1 to a set of MITF-associated regulatory elements (MAREs) at active enhancers. Combinations of MITF, SOX10, TFAP2A, and YY1 bind between two BRG1-occupied nucleosomes thus defining both a signature of transcription factors essential for the melanocyte lineage and a specific chromatin organisation of the regulatory elements they occupy. BRG1 also regulates the dynamics of MITF genomic occupancy. MITF-BRG1 interplay thus plays an essential role in transcription regulation in melanoma.
Collapse
Affiliation(s)
- Patrick Laurette
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Thomas Strub
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Dana Koludrovic
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Céline Keime
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Stéphanie Le Gras
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Hannah Seberg
- University of Iowa College of Medicine, Iowa City, United States
| | | | - Hana Imrichova
- Laboratory of Computational Biology, Center for Human Genetics, University of Leuven, Leuven, Belgium
| | - Robert Siddaway
- Arthur and Sonia Labatt Brain Tumor Research Centre, Peter Gilgan Centre for Research and Learning, Hospital for Sick Children, Toronto, Canada
| | - Stein Aerts
- Laboratory of Computational Biology, Center for Human Genetics, University of Leuven, Leuven, Belgium
| | - Robert A Cornell
- University of Iowa College of Medicine, Iowa City, United States
| | - Gabrielle Mengus
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| | - Irwin Davidson
- Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
| |
Collapse
|
23
|
Martel PP, Miskimen R, Aguar-Bartolome P, Ahrens J, Akondi CS, Annand JRM, Arends HJ, Barnes W, Beck R, Bernstein A, Borisov N, Braghieri A, Briscoe WJ, Cherepnya S, Collicott C, Costanza S, Denig A, Dieterle M, Downie EJ, Fil'kov LV, Garni S, Glazier DI, Gradl W, Gurevich G, Hall Barrientos P, Hamilton D, Hornidge D, Howdle D, Huber GM, Jude TC, Kaeser A, Kashevarov VL, Keshelashvili I, Kondratiev R, Korolija M, Krusche B, Lazarev A, Lisin V, Livingston K, MacGregor IJD, Mancell J, Manley DM, Meyer W, Middleton DG, Mushkarenkov A, Nefkens BMK, Neganov A, Nikolaev A, Oberle M, Ortega Spina H, Ostrick M, Ott P, Otte PB, Oussena B, Pedroni P, Polonski A, Polyansky V, Prakhov S, Rajabi A, Reicherz G, Rostomyan T, Sarty A, Schrauf S, Schumann S, Sikora MH, Starostin A, Steffen O, Strakovsky II, Strub T, Supek I, Thiel M, Tiator L, Thomas A, Unverzagt M, Usov Y, Watts DP, Witthauer L, Werthmüller D, Wolfes M. Measurements of double-polarized compton scattering asymmetries and extraction of the proton spin polarizabilities. Phys Rev Lett 2015; 114:112501. [PMID: 25839263 DOI: 10.1103/physrevlett.114.112501] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2014] [Indexed: 06/04/2023]
Abstract
The spin polarizabilities of the nucleon describe how the spin of the nucleon responds to an incident polarized photon. The most model-independent way to extract the nucleon spin polarizabilities is through polarized Compton scattering. Double-polarized Compton scattering asymmetries on the proton were measured in the Δ(1232) region using circularly polarized incident photons and a transversely polarized proton target at the Mainz Microtron. Fits to asymmetry data were performed using a dispersion model calculation and a baryon chiral perturbation theory calculation, and a separation of all four proton spin polarizabilities in the multipole basis was achieved. The analysis based on a dispersion model calculation yields γ(E1E1)=-3.5±1.2, γ(M1M1)=3.16±0.85, γ(E1M2)=-0.7±1.2, and γ(M1E2)=1.99±0.29, in units of 10(-4) fm(4).
Collapse
Affiliation(s)
- P P Martel
- Department of Physics, University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
- Department of Physics, Mount Allison University, Sackville, New Brunswick E4L 1E6, Canada
| | - R Miskimen
- Department of Physics, University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | | | - J Ahrens
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - C S Akondi
- Department of Physics, Kent State University, Kent, Ohio 44242, USA
| | - J R M Annand
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - H J Arends
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - W Barnes
- Department of Physics, University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - R Beck
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, D-53115 Bonn, Germany
| | - A Bernstein
- Laboratory for Nuclear Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - N Borisov
- Joint Institute for Nuclear Research (JINR), 141980 Dubna, Russia
| | | | - W J Briscoe
- Department of Physics, The George Washington University, Washington, D.C. 20052, USA
| | - S Cherepnya
- Lebedev Physical Institute, 119991 Moscow, Russia
| | - C Collicott
- Department of Physics and Atmospheric Science, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada
- Department of Astronomy and Physics, Saint Marys University, Halifax, Nova Scotia B3H 3C3, Canada
| | - S Costanza
- INFN Sezione di Pavia, I-27100 Pavia, Italy
| | - A Denig
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - M Dieterle
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - E J Downie
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
- Department of Physics, The George Washington University, Washington, D.C. 20052, USA
| | - L V Fil'kov
- Lebedev Physical Institute, 119991 Moscow, Russia
| | - S Garni
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - D I Glazier
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
- School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - W Gradl
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - G Gurevich
- Institute for Nuclear Research, 125047 Moscow, Russia
| | - P Hall Barrientos
- School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - D Hamilton
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - D Hornidge
- Department of Physics, Mount Allison University, Sackville, New Brunswick E4L 1E6, Canada
| | - D Howdle
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - G M Huber
- Department of Physics, University of Regina, Regina, Saskatchewan S4S 0A2, Canada
| | - T C Jude
- School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - A Kaeser
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | | | - I Keshelashvili
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - R Kondratiev
- Institute for Nuclear Research, 125047 Moscow, Russia
| | - M Korolija
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - B Krusche
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - A Lazarev
- Joint Institute for Nuclear Research (JINR), 141980 Dubna, Russia
| | - V Lisin
- Institute for Nuclear Research, 125047 Moscow, Russia
| | - K Livingston
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - I J D MacGregor
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - J Mancell
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - D M Manley
- Department of Physics, Kent State University, Kent, Ohio 44242, USA
| | - W Meyer
- Institut für Experimentalphysik, Ruhr-Universität, D-44780 Bochum, Germany
| | - D G Middleton
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
- Department of Physics, Mount Allison University, Sackville, New Brunswick E4L 1E6, Canada
| | - A Mushkarenkov
- Department of Physics, University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - B M K Nefkens
- Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, California 90095-1547, USA
| | - A Neganov
- Joint Institute for Nuclear Research (JINR), 141980 Dubna, Russia
| | - A Nikolaev
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, D-53115 Bonn, Germany
| | - M Oberle
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - H Ortega Spina
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - M Ostrick
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - P Ott
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - P B Otte
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - B Oussena
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - P Pedroni
- INFN Sezione di Pavia, I-27100 Pavia, Italy
| | - A Polonski
- Institute for Nuclear Research, 125047 Moscow, Russia
| | - V Polyansky
- Lebedev Physical Institute, 119991 Moscow, Russia
| | - S Prakhov
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
- Department of Physics, The George Washington University, Washington, D.C. 20052, USA
- Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, California 90095-1547, USA
| | - A Rajabi
- Department of Physics, University of Massachusetts Amherst, Amherst, Massachusetts 01003, USA
| | - G Reicherz
- Institut für Experimentalphysik, Ruhr-Universität, D-44780 Bochum, Germany
| | - T Rostomyan
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - A Sarty
- Department of Astronomy and Physics, Saint Marys University, Halifax, Nova Scotia B3H 3C3, Canada
| | - S Schrauf
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - S Schumann
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - M H Sikora
- School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - A Starostin
- Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, California 90095-1547, USA
| | - O Steffen
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - I I Strakovsky
- Department of Physics, The George Washington University, Washington, D.C. 20052, USA
| | - T Strub
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - I Supek
- Rudjer Boskovic Institute, HR-10000 Zagreb, Croatia
| | - M Thiel
- II. Physikalisches Institut, Universität Giessen, D-35392 Giessen, Germany
| | - L Tiator
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - A Thomas
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| | - M Unverzagt
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
- Helmholtz-Institut für Strahlen- und Kernphysik, Universität Bonn, D-53115 Bonn, Germany
| | - Y Usov
- Joint Institute for Nuclear Research (JINR), 141980 Dubna, Russia
| | - D P Watts
- School of Physics, University of Edinburgh, Edinburgh EH9 3JZ, United Kingdom
| | - L Witthauer
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - D Werthmüller
- Departement Physik, Universität Basel, CH-4056 Basel, Switzerland
| | - M Wolfes
- Institut für Kernphysik, Universität Mainz, D-55099 Mainz, Germany
| |
Collapse
|
24
|
White B, Tilse C, Wilson J, Rosenman L, Strub T, Feeney R, Silvester W. Prevalence and predictors of advance directives in Australia. Intern Med J 2014; 44:975-80. [DOI: 10.1111/imj.12549] [Citation(s) in RCA: 74] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2014] [Accepted: 08/05/2014] [Indexed: 11/28/2022]
Affiliation(s)
- B. White
- Australian Centre for Health Law Research, Faculty of Law; Queensland University of Technology; Brisbane Queensland Australia
| | - C. Tilse
- School of Social Work and Human Services; The University of Queensland; Brisbane Queensland Australia
| | - J. Wilson
- School of Social Work and Human Services; The University of Queensland; Brisbane Queensland Australia
| | - L. Rosenman
- Collaborative Research Networks Program Leader; Charles Darwin University; Darwin Northern Territory Australia
| | - T. Strub
- Criminal Justice Research; Department of the Premier and Cabinet; Queensland Government; Brisbane Queensland Australia
| | - R. Feeney
- School of Social Work and Human Services; The University of Queensland; Brisbane Queensland Australia
| | - W. Silvester
- Respecting Patient Choices Program; Austin Health; Melbourne Victoria Australia
| |
Collapse
|
25
|
Strub T. Polarization Observables Tand Fin single π0- and η-Photoproduction off quasi-free Nucleons. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20148102021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
|
27
|
Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, Davidson I. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 2011; 30:2319-32. [PMID: 21258399 DOI: 10.1038/onc.2010.612] [Citation(s) in RCA: 187] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Malignant melanoma is an aggressive cancer known for its notorious resistance to most current therapies. The basic helix-loop-helix microphthalmia transcription factor (MITF) is the master regulator determining the identity and properties of the melanocyte lineage, and is regarded as a lineage-specific 'oncogene' that has a critical role in the pathogenesis of melanoma. MITF promotes melanoma cell proliferation, whereas sustained supression of MITF expression leads to senescence. By combining chromatin immunoprecipitation coupled to high throughput sequencing (ChIP-seq) and RNA sequencing analyses, we show that MITF directly regulates a set of genes required for DNA replication, repair and mitosis. Our results reveal how loss of MITF regulates mitotic fidelity, and through defective replication and repair induces DNA damage, ultimately ending in cellular senescence. These findings reveal a lineage-specific control of DNA replication and mitosis by MITF, providing new avenues for therapeutic intervention in melanoma. The identification of MITF-binding sites and gene-regulatory networks establish a framework for understanding oncogenic basic helix-loop-helix factors such as N-myc or TFE3 in other cancers.
Collapse
Affiliation(s)
- T Strub
- Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, Université de Strasbourg, Illkirch, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Letelier RM, Karl DM, Abbott MR, Flament P, Freilich M, Lukas R, Strub T. Role of late winter mesoscale events in the biogeochemical variability of the upper water column of the North Pacific Subtropical Gyre. ACTA ACUST UNITED AC 2000. [DOI: 10.1029/1999jc000306] [Citation(s) in RCA: 87] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|